Trimodality therapy in variant urothelial carcinoma: choose wisely

Panagiotis J Vlachostergios¹, Christopher Jakubowski¹, Scott T Tagawa^{1

2

3}

Affiliations

¹ Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
² Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
³ Department of Urology, Weill Cornell Medicine, New York, NY, USA.

Editorial

Panagiotis J Vlachostergios et al. Transl Androl Urol. 2017 Apr.

. 2017 Apr;6(2):322-325.

doi: 10.21037/tau.2017.03.59.

Panagiotis J Vlachostergios¹, Christopher Jakubowski¹, Scott T Tagawa^{1

2

3}

¹ Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
² Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
³ Department of Urology, Weill Cornell Medicine, New York, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.
Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA. Krasnow RE, et al. Eur Urol. 2017 Jul;72(1):54-60. doi: 10.1016/j.eururo.2016.12.002. Epub 2016 Dec 28. Eur Urol. 2017. PMID: 28040351

1. Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017;71:462-75. 10.1016/j.eururo.2016.06.020 - DOI - PubMed
1. Milowsky MI, Rumble RB, Booth CM, et al. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol 2016;34:1945-52. 10.1200/JCO.2015.65.9797 - DOI - PubMed
1. Arcangeli G, Strigari L, Arcangeli S. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials. Crit Rev Oncol Hematol 2015;95:387-96. 10.1016/j.critrevonc.2015.04.006 - DOI - PubMed
1. Willis D, Kamat AM. Nonurothelial bladder cancer and rare variant histologies. Hematol Oncol Clin North Am 2015;29:237-52. 10.1016/j.hoc.2014.10.011 - DOI - PubMed
1. Abd El-Latif A, Watts KE, Elson P, et al. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. J Urol 2013;189:1263-7. 10.1016/j.juro.2012.10.054 - DOI - PubMed